Cardiac Drug Therapy

Dr. M. Gabriel Khan is a cardiologist at the Ottawa Hospital and an Associate Profes­sor of Medicine, at the University of Ottawa. Dr. Khan graduated MB, BCh, with First-Class Honours at The Queen’s University of Belfast. He obtained , by thesis, the Degree  of  Doctor of Medicine  with  Honours ( QUB). He is the author of Encyclopedia of Heart Diseases, Academic Press/ Elsevier, 2006; Encyclopedia of Heart Diseases,  2nd ed., Springer Science+Business Media,  2011; Rapid ECG Interpretation, 3rd ed.,  Humana Press/Springer Science+Business Media, 2008;  On Call Cardiology, 3rd  ed., Elsevier, 2006; Heart Disease Diagnosis and Therapy, 2nd ed., Humana Press, 2006; Cardiac and Pulmonary Management (1993); Medical Diagnosis and Therapy (1994); Heart Attacks, Hypertension and Heart Drugs (1986); and Heart Trouble Encyclopedia (1996).

From the book reviews: "This excellent book serves as a complete guide to therapeutic strategies for patients with cardiac diseases. ... This is an excellent guide for any practitioner prescribing cardiac medications, including medical students, residents, fellows, general practitioners, and consultants. ... This is a quick and easy read, presenting comprehensive and up-to-date information. ... This book is well written and suitable for those at various levels of training involved in prescribing cardiac medications." (Parham Parto, Doody's Book Reviews, February, 2015)

• Beta-Blockers: The Cornerstone of Cardiac Drug Therapy.- Beta-Blocker Controversies.- Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers.- ACE Inhibitor Controversies.- Calcium Antagonists (Calcium Channel Blockers).- Calcium Antagonist Controversies.- Diuretics.- Hypertension.- Hypertension Controversies.- Angina.- Acute Myocardial Infarction.- Heart Failure.- Heart Failure Controversies.- Management of Cardiac Arrhythmias.- Cardiac Arrest.- Management of Infective Endocarditis.- Dyslipidemias.- Endocrine Heart Diseases.- Antiplatelet Agents, Anticoagulants, Factor XA Inhibitors, Thrombin Inhibitors.- Cardiac Drugs During Pregnancy and Lactation.- Effects of Drug Interactions.- Hallmark Clinical Trials.- Management of Cardiomyopathies.- Newer Agents.